World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02357589
Date of registration: 03/02/2015
Prospective Registration: No
Primary sponsor: Helsinki University Central Hospital
Public title: 3D vs 2D HD Laparoscopy in Cholecystectomy
Scientific title: 3 Versus 2 Dimensional HD Laparoscopy in Cholecystectomy: a Prospective, Single Blinded, Randomized, Controlled Trial
Date of first enrolment: January 2015
Target sample size: 210
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02357589
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).  
Phase:  N/A
Countries of recruitment
Finland
Contacts
Name:     Ville Sallinen, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Helsinki University Central Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients scheduled for laparoscopic cholecystectomy

Exclusion Criteria:

- Some other surgical operation planned during LCC

- Expected major risk of conversion (e.g. multiple previous abdominal operation,
previous peritonitis, previous cholecystitis)

- Operating surgeon experience less than 5 3D laparoscopy operations



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Cholecystolithiasis
Intervention(s)
Procedure: 2D laparoscopic cholecystectomy
Procedure: 3D laparoscopic cholecystectomy
Primary Outcome(s)
Duration of surgery [Time Frame: Expected average time of surgery 1 hour]
Secondary Outcome(s)
Mortality [Time Frame: 30 days after randomization]
Postoperative pain, VAS [Time Frame: Expected range 0-7 day]
Intraoperative complications [Time Frame: During the operation, expected average time of surgery 1 hour]
Postoperative stay in hospital [Time Frame: Expected range 0-7 day]
Need for conversion into open surgery [Time Frame: During the operation, expected average time of surgery 1 hour]
Bleeding [Time Frame: During the operation, expected average time of surgery 1 hour]
Total need of opioids in milligrams [Time Frame: Expected range 0-7 day]
Operation theatre time [Time Frame: Expected average 1,5 hours]
Complications, Clavien-Dindo classification [Time Frame: 30 days after randomization]
Number of participants with readmission(s) [Time Frame: 30 days after randomization]
Secondary ID(s)
HUCH-328-150127
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history